-+ 0.00%
-+ 0.00%
-+ 0.00%

AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJÖGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026

Reuters·09/22/2026 13:02:13